Home › Funds › SIG BROKERAGE, LP › VRTX

SIG BROKERAGE, LP position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

SIG BROKERAGE, LP reported holding 22,390 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 0.81% of its reported portfolio and ranking #23 among its reported holdings. SIG BROKERAGE, LP has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)22.39K sh
Reported value held$11.12M
Portfolio Weight0.81%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SIG BROKERAGE, LP's VRTX position evolved

SIG BROKERAGE, LP first disclosed a stake in VRTX in Q4 2024 at 1,938 shares (US$780K). The position peaked in Q2 2026 at 22,390 shares, worth US$11.1M. Across 7 filings, SIG BROKERAGE, LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 22,390 shares valued at US$11.1M — an increase of 4,785 shares quarter over quarter.. Notable position changes include a 570% increase in Q2 2025 (shares fell 12% over the following quarter), a 50% trim in Q4 2025 (shares fell 1% over the following quarter), a 780% increase in Q1 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.94K $780.43K New
Q1 2025 1.12K $543.00K Reduce
Q2 2025 7.50K $3.34M Add
Q3 2025 4.00K $1.57M Reduce
Q4 2025 2.00K $906.72K Reduce
Q1 2026 17.61K $7.86M Add
Q2 2026 22.39K $11.12M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has SIG BROKERAGE, LP held VRTX?

SIG BROKERAGE, LP has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is SIG BROKERAGE, LP's current position in VRTX?

As of Q2 2026, SIG BROKERAGE, LP holds 22.39K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $11.12M, representing 0.81% of its reported portfolio and ranking #23.

Has SIG BROKERAGE, LP been buying or selling VRTX?

In the latest 13F filing (Q2 2026), SIG BROKERAGE, LP increased its position in VRTX. The position peaked in Q2 2026 at 22.39K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.